WO2003046526A1 - Spr-sensorflächenträger - Google Patents
Spr-sensorflächenträger Download PDFInfo
- Publication number
- WO2003046526A1 WO2003046526A1 PCT/EP2002/013008 EP0213008W WO03046526A1 WO 2003046526 A1 WO2003046526 A1 WO 2003046526A1 EP 0213008 W EP0213008 W EP 0213008W WO 03046526 A1 WO03046526 A1 WO 03046526A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- areas
- spr sensor
- spr
- measuring
- carrier
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/251—Colorimeters; Construction thereof
- G01N21/253—Colorimeters; Construction thereof for batch operation, i.e. multisample apparatus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/55—Specular reflectivity
- G01N21/552—Attenuated total reflection
- G01N21/553—Attenuated total reflection and using surface plasmons
Definitions
- the present application relates to an SPR
- SPR Surface Plasmon Resonance
- Sensor surface support is known for example from WO 01/63256 AI.
- the present application further relates to a
- WO 01/63256 describes a structured SPR sensor surface carrier which consists of a glass substrate on which a multiplicity of SPR sensor surfaces are arranged in a two-dimensional grid lying in one plane, radiation for excitation of surface plasmons being guided through the substrate becomes. Separating means are also provided in order to separate the individual SPR sensor areas from the respectively adjacent SPR sensor areas. The sensor areas are formed, for example, by a gold layer on the substrate, and the release agents, for example, by a lacquer or silicon on the substrate, so that no surface plasmon resonance occurs in the area of the release agents. Likewise, according to an example shown, the separating means are raised compared to the SPR sensor surfaces, so that the separating means form a respective cavity for each SPR sensor surface.
- the SPR sensor surface support described provides a means for simultaneously measuring a large number of sensor surfaces. The object of the present invention is to improve such an SPR sensor surface carrier.
- the SPR sensor surface carrier is divided into a multiplicity of measuring ranges, one measuring range each comprising one or more (e.g. four) SPR sensor surfaces, and at least one of these measuring ranges from one
- Is surrounded insulation area which does not include a release agent, and is designed to accommodate a sealing element in order to form, together with a volume element to be placed on the measurement area, a space isolated from adjacent measurement areas above this given measurement area.
- an SPR sensor surface carrier is created, which gives the possibility of creating a volume over one or more measuring regions, which is isolated from neighboring measuring regions, in order, for example, to carry out further measurements on samples directly on the SPR sensor surface carrier respective SPR sensor surfaces.
- La-lc show perspective views of SPR sensor surface carriers according to the invention.
- FIG. 2 shows a sectional perspective view and an enlarged section of an SPR sensor surface carrier according to the invention and a volume element;
- FIG 3 shows a sectional view and a perspective view of a measuring area and associated sealing element.
- FIG. 1 a A first embodiment of the invention is shown in FIG. 1 a, in which a multiplicity of measurement areas 110, each comprising four SPR sensor surfaces 100 in the example shown, are arranged on a prism 4, which in this example serves as the substrate of the SPR sensor surface carrier serves. Also shown is a cell border 9, which preferably surrounds the overall arrangement of measurement areas 110 is attached. Also shown is a light beam 6 which is guided through the prism 4 (the SPR sensor surface support) in order to excite surface plasmon resonance in the SPR sensor surfaces 100.
- FIG. 1b shows a further embodiment of the invention, in which a plate-shaped substrate 5 carries the SPR sensor surfaces 100 and the measuring areas 110. Similar to the embodiment in FIG. 1 a, a cell border 9 is also provided.
- this SPR sensor surface carrier it is applied to a surface 7 of a prism 4, so that light (more generally: SPR-exciting radiation) 6 can be guided through the prism 4 and the plate 5 to the SPR sensor surfaces 100 , This is preferably done by using an index liquid 8 between the prism 4 and the plate 5, so that the light 6 irradiated under SPR conditions is not reflected at the interface of the surface 7 at the air gap in front of the plate 5.
- an index liquid is oleic acid or a mixture containing oleic acid.
- any material that is transparent for SPR-capable radiation and onto which a SPR-capable material can be applied in the SPR sensor areas 100 can be used as the material for the prism 4 or the plate 5.
- the substrate 4 or 5 can be made of glass, and the SPR sensor surfaces can be formed by a metal coating, in particular by a gold layer.
- the measuring areas 110 can be addressed in two dimensions.
- the term "addressable" in this context means that individual measuring ranges by means of a corresponding Identification or address can be distinguished from one another, so that corresponding samples can also be addressed accordingly. This creates the advantage that a very large number of measuring areas 110 can be exposed and evaluated simultaneously. However, it is also possible within the scope of the invention to arrange the measuring ranges in one dimension in an addressable manner.
- the measuring areas 110 are arranged in a Cartesian grid, as shown in FIG. 1, the addressability then being given most simply by Cartesian coordinates.
- the present invention is in no way limited to this, and the measuring ranges can be distributed in any grid or even completely disordered, and can be addressed according to any coordinates (e.g. polar coordinates) regardless of their specific arrangement.
- the carrier 5 is shown schematically, on which a gold layer 51 is located.
- the measuring area 110 comprises four SPR sensor areas 100.
- a measuring area can also include more or fewer SPR sensor areas 100.
- the measuring area 110 is formed by suitable separating means 105 (examples of which are described later) which, as shown in FIG.
- SPR sensor areas 100 are formed in which the gold layer is applied to the carrier 5 (possibly with an intermediate layer for promoting adhesion between the gold layer 51 and the carrier 5) and release agent regions in which the release agent 105 on the carrier or substrate 5 (also possibly with an adhesion-promoting agent Intermediate layer) are applied.
- the separating means are designed such that no surface resonance occurs there , so that the SPR sensor surfaces are clearly separated from one another by the structuring of the surface of the carrier 5.
- the measuring area 110 shown is surrounded by an insulating area 120.
- the insulating area 120 is designed to accommodate a sealing element 130 in order to form an insulated space over this measuring area together with a volume element 11 to be placed on the measuring area 110 shown (see FIG. 3 above).
- the insulating region 120 does not comprise any separating means 105. This ensures that the sealing element 130 can provide a good seal.
- the insulating region 120 on the surface facing away from the substrate 5 is preferably of the same nature as the SPR sensor surfaces. This can be seen in FIG. 3 above, since both the SPR sensor area and the insulating area 120 present the gold area 51. According to a preferred embodiment, not only are the surfaces made the same, but the SPR sensor surfaces and insulation areas are made the same overall, i.e. have the same layer sequence from the substrate 5 to the surface. In other words, the SPR sensor surfaces 100 and the insulating regions 120 are preferably produced by the same method steps, so that no separate method steps are necessary for the respective production.
- the insulating region 120 may be different on the surface facing away from the substrate 5 is configured as the SPR sensor areas 100.
- an isolation region 120 may be formed by an exposed substrate surface.
- an insulating region 120 it is possible for an insulating region 120 to have a seal-demanding layer on its surface, which consists of a material that is matched to the sealing elements 130, for example silicone. This seal-promoting layer can be applied in any desired or practical way, for example by means of a mask, by means of a robot which controls the individual insulation areas, or also by hand.
- the separating means 105 are raised not only with respect to the SPR sensor areas in order to form respective cavities on the SPR sensor areas, but also with respect to the insulating area 120, as shown in FIG. 3. With suitable dimensioning of the insulating region 120 and the sealing element 130, it is thus possible for the separating means 105, which form the circumference of the measuring region 110, to serve as a guide for the sealing element 130. The placement of the sealing elements 130 is thus facilitated.
- the measuring areas 110 and the associated sealing elements 130 are preferably round or oval. However, it should be noted that the invention can be applied to any geometric shapes of the outer circumference of measuring areas and sealing elements.
- FIG. 3 shows a single measuring area 110 with an associated insulating area 120.
- FIG. 1 shows a plurality of measurement areas (as shown in FIG. 1) and only one or a few of these measurement areas are surrounded by associated isolation areas, it is preferred that each of the plurality of measurement areas 110 of a given SPR- Sensor surface carrier is surrounded by an associated insulating area 120. This gives the advantage that by putting on a corresponding volume element and volume element over any measurement area 110, a volume can be formed in order to carry out further measurements and analyzes.
- a method for producing an SPR sensor surface carrier according to the above-described embodiments is now set out. This is preferably done by forming or applying the release agent 105 on the respective substrate, e.g. of the plate 5 or the prism 4, so that free areas are created between the separating means 105, which define SPR sensor areas 110 and insulating areas 120, and then application of an SPR-suitable material at least in the free areas, which define SPR sensor areas 100.
- an SPR sensor area carrier is created in which the insulating areas are characterized by the exposed substrate or the layer directly below the gold layer. If the SPR-suitable material is also applied in the free areas which define insulating areas, an SPR sensor surface carrier is produced, as is shown in FIG. 3, namely in which the SPR-suitable layer both in the SPR sensor surfaces 100 and in the isolation areas 120 is presented.
- SPR-suitable material e.g. gold
- a seal-demanding layer e.g. silicone
- the step for forming the release agent 105 can be carried out, for example, by applying a polymer to the surface of the substrate 4 or 5.
- This preferably comprises the steps of applying a photostructurable polymer to the entire surface of the substrate 4 or 5, exposing the applied polymer layer with a mask defining areas associated with the release means 105, areas associated with the SPR sensor areas 100 and areas associated with the isolation areas 120, and processing the exposed polymer layer to include in the areas belonging to the SPR sensor areas 100 and the isolation areas 120 to expose the substrate surface.
- An alternative in applying a polymer for the release agent is to apply a polymer to the surface of the substrate 4 or 5 in a two-dimensional grid that defines the release agent 105, the SPR sensor surfaces 100 and the insulating regions 120, and the curing of the Polymers.
- the polymer is preferably applied using a screen printing technique.
- the release agent can also be formed by a structurable silicon layer.
- the step for applying the SPR-suitable material is preferably carried out by depositing a metal, an adhesion-promoting layer possibly being applied prior to the deposition of the metal. It is particularly preferred that the metal is evaporated on the entire surface of the structured substrate, so that it then also covers the release agents, as shown schematically in FIG. 3 above.
- the SPR sensor surface support according to the invention is designed in such a way that the insulating area 120 can accommodate a sealing element 130 in order to form an insulated space above the measuring area together with a volume element 11.
- the volume element 11 can be provided in any suitable or desired manner, for example as cylindrical single element which is connected to a single sealing element 130.
- several volume elements 11 are provided as part of a volume element carrier 10, as shown for example in FIG. 2.
- 2 shows a measuring device which consists of an SPR sensor surface carrier 5 and a volume element carrier 10, which interact with one another in such a way that spaces are formed over the respective measuring regions 110.
- the volume element carrier 10 is a body in which the volume elements 11 are formed as bores or recesses.
- the volume element carrier 10 can e.g. by machining (e.g. milling or drilling), from a plastic (e.g. Teflon) or metal (e.g. aluminum).
- Thermoplastics e.g. polystyrene or polypropylene
- the volume element carrier 10 can be a body in which the volume elements 11 are formed as bores or recesses.
- the volume element carrier 10 can e.g. by machining (e.g. milling or drilling), from a plastic (e.g. Teflon) or metal (e.g. aluminum).
- Thermoplastics e.g. polystyrene or polypropylene
- the volume element carrier 10 can be considered as alternative plastics, even if they are less suitable for machining than
- Volume element carriers can also be brought into the desired shape using a casting process (e.g. injection molding).
- a casting process e.g. injection molding
- any suitable, moldable or solidifying material is suitable, e.g. the above-mentioned thermoplastic elastomers, such as polystyrene or polypropylene, or castable metals.
- the volume element carrier is to be used repeatedly in processes in which viruses, bacteria or other potentially infectious biological entities are used, preference is given to materials which are resistant to chemical sterilization (for example treatment with citric acid, NaOH / SDS).
- a material is, for example, PolyChloroTriFluoroEthylen (PCTFE).
- PCTFE PolyChloroTriFluoroEthylen
- the sealing elements 130 are components of the volume element carrier 10.
- the sealing elements 130 can be connected to the volume element carrier 10 in a fixed or detachable manner. Grooves in which the sealing elements 130 are placed are preferably provided on the side of the body forming the volume element carrier around the openings which define volume elements 11. In this case, the sealing elements are preferably O-rings.
- sealing elements and the volume element carrier may be formed in one piece. This is e.g. possible if the volume element carrier is injection molded from a suitable plastic, which is sufficient flexibility for the
- the sealing elements can be formed on the side of the volume element carrier as protruding beads in a shape matched to the measuring areas (e.g. as ring beads for round or oval measuring areas).
- soft material seals are suitable as sealing elements, e.g. made of plastic, rubber, silicone, Teflon or similar, which can be used in ring, lamella or mat design. Vacuum seals can also be used.
- the SPR sensor surface support and the volume element support 10 have respective adjustment elements, e.g. Dowel pins and guides 13 (see Figure 2), so that
- Sealing elements 130 can be aligned with the assigned insulating areas 120.
- the tolerances for the dowel pins and guides are matched to the dimensions of the measuring areas or insulating areas and sealing elements, so that the desired accuracy of fit between the sealing elements and insulating areas can be achieved.
- the accuracy of fit of the dowel pins and guides is preferably on the order of 20 ⁇ m or less.
- the SPR sensor surface carrier and the volume element carrier have respective fastening elements 15 in order to firmly connect the SPR sensor surface carrier and the volume element carrier to one another.
- the fastening elements 15 are preferably such that the connection can also be released again.
- the connecting elements 15 can e.g. be a pressure connection, such as a screw or clamp connection.
- the fasteners can e.g. Be guides in which a metal clip is inserted to connect the SPR sensor surface support and the volume element support together.
- the connecting elements can be internally threaded bores into which an outer screw is screwed in order to connect the SPR sensor surface support and the volume element support to one another.
- Fasteners 15 are identical, e.g. would be possible in the example of the threaded holes given above, since screwing in the outer screw on the one hand connects the SPR sensor surface support and the volume element support, and on the other hand brings about an adjustment by the alignment of the holes.
- the tolerances must create the required accuracy of fit. It is therefore preferred that the adjusting elements 13 and the fastening elements 15 are separate, since then the requirements for the tolerances in the fastening elements can be lower.
- a method for the selection and identification of peptide or protein molecules by means of a phage display is now described, which is a preferred application of the SPR sensor surface carrier described above and that of SPR- Sensor surface support, sealing elements and volume elements existing measuring device.
- Phage display screening systems follow this approach.
- the combination of in vitro gene expression techniques and traditional biochemical techniques used follow this approach.
- genes coding for non-viral proteins or peptides are incorporated into the viral genome in such a way that fusion proteins are generated between the desired non-viral protein or peptide and a viral coat protein.
- the fusion protein is presented on the surface of the virus.
- a typical phage display library a large number of DNA fragments which code for non-viral proteins or peptides are inserted into the viral genome. This is how viral particles are generated that present a multitude of proteins or peptides on the surface.
- This phage display library is then brought into contact with a sample immobilized on a support. In the subsequent washing step, viruses that
- fusion proteins that interact with the immobilized sample to form a bond on which Retain carriers, whereas viruses that present non-interacting fusion proteins are washed away.
- the interacting viruses are eluted and amplified by infection of a host culture. Repeated rounds of amplification and selection may be required to obtain a relatively homogeneous virus population that binds to the immobilized sample with high affinity.
- the inserted DNA sections are then sequenced from individual virus clones and the amino acid sequences of the interacting proteins or peptides are derived therefrom.
- the immobilization of an interaction partner is necessary to enable the separation of the virus-ligand complexes from the non-interacting viruses. It also facilitates process management, e.g. performing washing steps and, in conjunction with a suitable detection method, can provide information about the presence and the strength of the interactions between the interaction partners.
- Spherical beads (cross-linked polymers in particle form) are often used as carriers for virus selection. Beads can, for example, be stacked up to form affinity columns. A big disadvantage with the
- a carrier for virus selection which immobilizes a large number of Ligands and a universal / simple handling guaranteed and thus enables automation and miniaturization of the process.
- the geometry of the carrier used for virus selection plays an important role in the automation and miniaturization of the method. It is advantageous for this if the interaction partners immobilized on the carrier are arranged in a regular grid and positionally addressable. For the automation and miniaturization of the method, it would also be very advantageous if both the selection and the detection of binding events could be carried out on the identical surface. In order to enable the easy use of powerful robots for pipetting or the like, the containers should also be open at the top.
- Microtiter plates or a planar support e.g. a membrane
- a planar support e.g. a membrane
- WO01 / 02554 describes a parallelized method for identifying interaction partners using phage
- a major disadvantage of using microtiter plates as an incubation vessel is that the cavities only have a relatively small sample volume (e.g. 0.2 - 1.2 ml volume per well for standard 96-well microtiter plates; 20-60 ⁇ l Allow 384 microtiter plates) for the selection. Due to this volume limitation of the cavities, it is often necessary to enrich the viruses before screening. For example, phage titers between lx 10 10 - lx 10 11 pfu / ml (plaque forming units) are usually achieved with lysates of bacteriophage T7.
- a method is more advantageous in which the culture supernatants / lysates resulting from the multiplication of the phage library can be used directly in the screening process. This is made possible by using incubation vessels with a larger sample volume than the cavities of microtiter plates allow.
- Another disadvantage is that a competing, simultaneous selection of structurally similar ligands against the phage library is excluded due to the separate volumes, since only one ligand can be immobilized per cavity.
- a selection of the in a common sample volume is advantageous Interaction partners in which the immobilized interaction partners are arranged in a position-addressable, two-dimensional array. Suitable for this are planar supports (eg membranes) which are incubated in suitable large-volume vessels (dishes or tubes) or which are themselves a vessel.
- Hawlisch et al. (Analytical Biochemistry 293, 142-145 (2001) describe a method for the selection of epitope-specific scFv fragments using an M13-based virus system. For the selection, a peptide array synthesized on cellulose membranes was used, which contains part of the primary sequence of the human C3a receptor in Form of fifty in sequence overlapping 15mer peptides represented.
- Binding partners to the individual affinity ligands of the array used for the selection were carried out by further ELISA-based assays. For this purpose, the entire array was brought into contact with a single virus clone and the assignment of the virus clone to one or more affinity ligands of the array was made via the position of the binding signal. For every virus clone a separate assay must therefore be carried out against all affinity ligands contained in the array. The viral clones were assigned to the individual affinity ligands immobilized in the array in a further binding assay (ELISA) which was carried out on the array.
- ELISA binding assay
- a disadvantage of this method is that a common ELISA for the identification of interacting viral clones is only possible when using peptidic affinity ligands which are derived from a common protein / polypeptide sequence.
- a binding assay must be performed for each affinity ligand used in the array.
- a disadvantage of using membranes as the surface is that the local concentration of the ligand can only be controlled with great effort. This can lead to the formation of unspecific virus-ligand complexes due to local avidity effects.
- a very great disadvantage of the above-mentioned prior art method is that the spatial information of the array with respect to the ligands is lost during the selection because the interacting viruses i) cannot be detected on the array and ii) do not elute from the array in a location-specific manner can be.
- a measurement system is required with which the binding of the viruses can be detected during the selection, and ii) a method by means of which bound viruses are required location-specific can be eluted from the array.
- the selection and detection of the selection success must be able to be carried out in the same measuring system.
- the binding assay on which the selection is based is limited in its execution to the conditions of the labeling reaction, so that a variation of the binding assay which is advantageous for the selection, e.g. B. Changing the pH, the ionic strength or the use of detergents is not possible.
- marker-based detection method used in the above-mentioned method is that the viruses identified in the selection process cannot be used for the further method steps.
- marker molecules e.g. antibodies, streptavidin
- these require a physical interaction between the ligand-virus complexes and the labeling reagent. This physical interaction can lead to a change in the binding between the ligand and the virus (weakening or strengthening) or to an impairment of the host-virus interaction (loss of infectivity).
- marker-based detection methods it is to be expected that insoluble aggregates will form, so that the viruses contained therein are not available for further process steps.
- a label-free detection method such as surface plasmon resonance (SPR)
- SPR surface plasmon resonance
- This also has the advantage that the direct binding of the peptide or protein presented on the virus to the ligand can be demonstrated.
- the proteins used as ligands were each covalently coupled to the dextran matrix of a sensor chip in three different approaches and a limited volume of a phage library was passed over the sensor surface in a continuous flow.
- the viruses were then eluted from the surface using a mobile phase with continuous flow and the eluate was collected in a fractional manner.
- the course of the selection carried out on the sensor surface was observed by means of time-resolved SPR measurement in a BIAcore TM device.
- the viruses contained in the eluate were separated and multiplied.
- the primary selection success was the increase in the ratio of bindings to non-binders of the virus clones contained in the eluate, as determined by ELISA. Subsequently, the antibodies encoded by the interacting viruses were produced recombinantly and their dissociation constant compared to the ligand immobilized on the sensor chip was determined.
- a very big disadvantage of this method is that a flow system is used. As a result, the arrangement of the sensor surfaces in a one-dimensional direction is predetermined (one-dimensional array).
- the disadvantage here is that a two-dimensional sample arrangement (two-dimensional array) and its miniaturization is impossible, particularly through the use of a flow system.
- the method now to be described therefore aims to provide a highly parallelizable method for the selection and identification of peptide or protein molecules which can specifically interact with certain other molecules to form a bond, while avoiding or reducing the disadvantages of the prior art.
- the ligands are shown in a two-dimensional array as shown in FIG. 1, on the specifically designed
- Solid phase carrier or sensor surface carrier immobilized immobilized, the marker-free detection of interaction partners enabled by SPR.
- the selection and detection of the selection success can be carried out in one measuring system.
- the detected interacting viruses can be treated further in subsequent process steps and, if necessary, increased, using either all bound viruses or only those bound to surface fields selected for the respective selection.
- Another advantage of a label-free detection method is that the direct binding between the ligand and the peptide or protein presented on the virus is detected. This is not the case when using marker-based detection methods.
- this advantageous method in conjunction with a suitable measuring system also enables parallel detection with a high integration density.
- This provides a highly miniaturized and parallelized phage display method, so that the detection for several or all ligands can take place in parallel.
- the culture supernatants / lysates resulting from the multiplication of the phage library can be used directly in the screening process and thus the time-consuming enrichment of the viruses from the culture supernatants / lysate is not necessary. It is also advantageous that the selection takes place in a common sample volume and thus a competitive, simultaneous selection against a large number of ligands can be carried out.
- Steps (a) and (c) are preferably carried out on the same surface of the solid phase support, the ligands being immobilized in a Cartesian grid (array) on the surface of the solid phase support so that the position each ligand can be determined by its x and y coordinates on the array.
- a large number of position-addressable surface fields, also referred to as ligand fields, can also be provided on the solid phase support, whereupon the ligands are immobilized.
- the viruses not bound in step (a) are preferably removed in step (b) by elution.
- the solid phase support contains a polymer-free surface on which the ligands are immobilized. Due to the very high protein adsorption resistance of this polymer-free surface, it is possible to have relatively weak interactions, i.e. To observe the binding between the ligand and the protein or peptide molecule presented by the virus, which in particular enables the use of low molecular weight ligands.
- the host cells are preferably infected by the viruses bound to the surface of the solid phase support. This has the advantage that the binding between ligand and virus-presented peptide or protein does not have to be broken.
- the method allows the selection and identification of one or more representatives of peptide or
- Protein molecules from a large number of such molecules are represented by “representative” means that each different peptide or protein molecule does not usually occur as a single molecule in the multitude of molecules, but is present in the protein mixture in a more or less large amount.
- the principle of selection and identification is then based on the fact that the peptide or protein molecule sought can interact with one or more previously selected “selection molecules” while forming a bond.
- selection molecules are not particularly restricted in their nature and can be of any structure as long as they are in at all have such a test handled and capable of forming a bond. Here, they are simply referred to as "molecules".
- the term “ligand” is also used in the context of the present description for those molecules that are immobilized on the surface of the solid phase support.
- a peptide or protein molecule that is capable of interaction, ie binding to the ligand and can be selected and identified in this way, is also referred to as an “interaction partner”.
- identification * and “selection” in connection with the present description mean an enrichment, preferably an individualization of “interaction partners”. Consequently, both the identification of interaction partners in a large number or population of any number of different interaction partners, as well as the selection of individual ones in a previously enriched population are included.
- the interaction between the interaction partner and the ligand which manifests itself in the form of a bond between the partners, can be characterized, for example, with a “key and lock principle”.
- the interaction partner (peptide or protein) and the selection molecule (ligand) have structures or motifs that fit each other specifically, e.g. an antigenic determinant (epitope) that interacts with the antigen binding site of an antibody. Knowing the structure of one of the binding partners enables conclusions to be drawn about possible preferred structures or specific ones
- the interaction partners on the surface of viruses are presented as peptides or proteins.
- all peptides or proteins are encompassed, the coding nucleotide sequences of which are in one Virus genome can be inserted. It is preferred that the expression of these peptides or proteins as part of the virus envelope allows this envelope to be assembled and thus the virus to be propagated.
- the propagated virus is preferably infectious.
- peptides or proteins encompasses both natural and synthetic peptides or proteins.
- natural proteins include antibodies, antibody fragments, receptors that interact with their specific ligands, peptide ligands that interact with their specific receptors or peptide domains that interact with specific substrates , including proteins and coenzymes, and other peptides or enzymes, etc.
- proteins or peptides are also included.
- natural peptides accordingly include, among other things, fragments of the proteins described above, which interact with specific ligands, synthetic proteins or peptides comprise both pseudogenes or fragments thereof expressed as well as proteins or peptides with a random amino acid sequence
- the peptides and proteins are thus preferably part of a library consisting of viruses, the Viruses, preferably integrated into their genome, contain a nucleic acid sequence which encodes the corresponding peptide or protein.
- This nucleic acid sequence is typically present in such a way that, when expressed, it leads to the synthesis of the peptide or protein as part of a fusion protein which consists of a coat protein of the virus or a part thereof and of the peptide or protein.
- This fusion protein then has the ability to be localized on the surface of the virus and consequently to present the peptide or protein.
- ligand in connection with the method or measuring system described here describes molecules or compounds that are on the surface of a solid phase support be immobilized.
- the term encompasses macromolecules as well as "small organic molecules”.
- structural elements are generally referred to as ligands which, due to their structural peculiarities, presented interactions with viruses
- Peptides or proteins can enter. By knowing the structure of the ligands, conclusions can be drawn about the possible structure or special structural elements of the molecule presented on the virus.
- macromolecules is understood to mean molecules with a high molecular complexity or a high molecular weight. These are preferably biomolecules, e.g. Biopolymers, especially proteins, oligo- or polypeptides, but also DNA, RNA, oligo- or polynucleotides, isoprenoids, lipids, carbohydrates (glycosides), and their modifications, as well as synthetic molecules.
- biomolecules e.g. Biopolymers, especially proteins, oligo- or polypeptides, but also DNA, RNA, oligo- or polynucleotides, isoprenoids, lipids, carbohydrates (glycosides), and their modifications, as well as synthetic molecules.
- receptors in particular come into consideration, but also proteins or peptides which represent epitopes or antigenic determinants of proteins.
- the proteins can also be fusion proteins.
- small molecules or “low-molecular molecules” is understood to mean molecules which are of less molecular complexity than the macromolecules defined above.
- the term “small molecules” or “low molecular weight molecules” is not used uniformly.
- WO 89/03041 and WO 89/03042 describe molecules with molecular weights of up to 7000 g / mol as small molecules. Usually, however, molecular weights between 50 and 3000 g / mol are given, but more often between 75 and 2000 g / mol and mostly in the range between 100 and 1000 g / mol.
- small organic molecules is used for molecules with a
- small molecules include oligomers or small organic molecules, such as oligopeptides, oligonucleotides, carbohydrates (glycosides),
- One aspect of the method or measuring system used here relates to the provision of a two-dimensional array with a large number of ligands on an SPR sensor surface carrier according to the invention.
- the ligands in the array are arranged such that the identity of each ligand can be determined by its x and y coordinates on the array.
- the spatial structure of the resulting array is predetermined by a mechanical structuring of the carriers, which therefore preferably have a large number of regularly arranged, position-addressable fields (ligand fields).
- ligand fields contain one or more cavities (sensor fields), on the bottom of which the ligands are immobilized.
- the cavities preferably have a depth of 20-100 ⁇ m.
- ligand fields preferably differ in each case in the type of interaction partner immobilized on their sensor fields, it being possible for a single ligand field to present both a single ligand and also several identical or different ligands. In one In a typical example, four interaction partners are immobilized per ligand field.
- the cavities are preferably arranged in such a way that a regular, preferably Cartesian, grid of columns and strips is formed on the carrier.
- the size and shape of the carrier can be chosen as desired and easily adapted to the detection system used.
- the spacing of the fields from one another should preferably be adapted to the microtiter format used or the format of the spotting device used.
- the number of fields on the solid phase support can also exceed the number of subunits of the microtiter plate, i.e. the density of the sensor fields on the solid phase support can be many times higher than the density of the subunits of the microtiter plate.
- a rectangular solid phase support may have 6144 fields, which can be filled with four conventional 1536 microtiter plates using a spotting robot.
- ligands In order to increase the throughput during screening, it is advantageous to immobilize as large a number of ligands as possible.
- a number of at least 10, preferably 96, particularly preferably 384, very particularly preferably 1536, still more preferably 4608, most preferably 9216 different representatives of ligands can be immobilized.
- immobilize the same ligand several times This can be useful, for example, for multiple determinations of the ligand-virus interaction in order to assess the quality of the selection process.
- the figures given therefore only take into account the ligands which differ from one another. It must also be taken into account that different sites of the ligand can be used to immobilize the ligands.
- the ligand thus has a different orientation on the surface and can sometimes show a different binding behavior. According to the invention, different orientations of a ligand are also understood as “different” ligands for simplification.
- the sensor fields can be structured in a cost-effective way by not using the sensor itself (preferably a prism) as a solid phase support and structuring it directly (see Fig. La), but instead one separate sample carrier is used as a solid phase carrier for ligand immobilization, which is placed on the sensor, see Fig. lb and associated description.
- SPR surface plasmon resonance
- the ligand can be immobilized directly or indirectly on the solid phase support. There are several ways of attaching ligands to a solid surface. A covalent, ionic or adsorptive bond can be mentioned here as an example. The covalent attachment of the ligand to the support is particularly preferred since this chemical bond is so stable that it permits complete denaturation of adhering proteins without impairing the surface properties.
- the ligand can be used unchanged or chemically modified. Chemical modification involves changing existing reactivities, such as activating existing functional groups or adding another molecule that enables direct or indirect attachment to the surface. Simple addition or substitution reactions can be used for this.
- a self-assembling monolayer (SAM) is often used here, which avoids adsorption of the ligand on the support.
- SAM self-assembling monolayer
- Self-assembly into a dense film is usually accomplished through the hydrophobic interaction of long chain hydrocarbons at one end of which there is a functional group that allows attachment to the support and at the other end that contains a functional group that enables ligand binding.
- connections that include these functional building blocks are also called anchors.
- the anchor can have a spacer portion, which preferably contains ethylene glycol units, which ensure low non-specific protein adsorption.
- diluent molecules are advantageously also added to the anchor molecules mentioned in order to control the concentration on the surface.
- a too dense surface concentration can be disadvantageous due to steric hindrance.
- Thinner molecules are structurally adapted to the anchor molecules, but they do not have a head group for the binding of the ligand, since this should be avoided. Furthermore, they are usually shorter than the anchor molecules in order to avoid impairing the accessibility of the ligand for the peptide or protein presented on the virus.
- a polymer such as dextran
- a polymer-free surface is preferred.
- Another advantage of a polymer-free surface is that, due to the low non-specific protein binding, there is no need to use blocking reagents in the selection process. This is particularly advantageous because of this Blocking reagents also have non-specific protein binding, which is thus avoided.
- Another advantage of polymer-free surfaces is that they can be regenerated very easily. For this purpose, reagents can be used which make it possible to regenerate the surface in a one-step process (eg SDS-containing solutions or methanol-trifluoroacetic acid mixtures).
- SAMs can be generated by chemisorbing alkylthiols onto a metal surface (e.g. gold).
- a metal surface e.g. gold
- the long-chain molecules pack themselves onto the solid phase as SAM, with the gold atoms being complexed by the sulfur functions.
- Another example is the silanization of glass or silicon with reactive silanes containing epoxy or amino groups, followed by acylation of the amino groups, for example with nucleoside derivatives
- the application of the ligands to be immobilized is not limited to special processes. For more precise localization of the active sites on the surface, conventional pipetting or spotting devices, for example, but also stamping or ink-jet processes can be applied.
- the non-interacting viruses according to step (b) of the method according to the invention can be removed by conventional methods known to the person skilled in the art. The non-interacting viruses are preferred by
- non-interacting viruses encompasses viruses which do not interact with the immobilized affinity ligand (s), ie do not bind to the ligand.
- An elution process is, for example, a washing process.
- the surface can be treated, for example, with suitable solutions, the composition of which ensures that the interaction of the interaction partner with the target molecule is not resolved.
- differently stringent elution conditions are also included, in which, for example, low-affinity interactions are dissolved and thus there is an enrichment or identification of high-affinity interaction partners.
- Such examples are known from the prior art, zBzB ® in T7Select System Manual, Fa. Novagen, Madison (USA) (TB1 78 06/00), p. 14ff.
- step (b) the sequence of steps (a), (b) is repeated one or more times before the detection step (c) is carried out.
- step (c) it is preferred to carry out the further treatment and multiplication steps one or more times, ie after step (b), the sequence of steps (d), (e), (a), (b) is repeated one or more times before the detection step (c) he follows.
- step (c) can be carried out before step (d). The repetition of these sequence of steps ensures a selective enrichment of viruses that present interaction partners of the immobilized ligands on their surface.
- step (c) of the method according to the invention can be carried out using conventional detection methods known to the person skilled in the art. which guarantee that viruses that were detected in the selection process can be used in the further process steps. This is the case when using label-free detection methods.
- the label-free detection of the interaction between the ligands and the interaction partners presented by the viruses in step (c) is based on surface plasmon resonance (SPR).
- a label-free detection method means that the same surface can be used both for the selection process and for the detection of binding events, which only requires a one-time surface evaluation and also enables an identical ligand presentation.
- the sensor fields are imaged on a spatially resolving detector.
- Each of the sensor fields can be used as a separate measurement surface, i.e. the binding of
- Phage particles can be detected separately for each sensor field.
- the detector should be able to record all binding events in parallel and the detection itself should be done in parallel.
- the detector is advantageously a CCD camera.
- An advantage of the parallel selection is that it promotes the comparability of the individual measurement results with one another.
- the light arriving at the intermediate regions of the ligand fields should be absorbed as much as possible, scattered away or directed away in a direction other than the detection direction. This is ensured by the separating means 105 in the SPR sensor surface carriers according to the invention. It is this contrast between the sensor field and the boundary that allows an assignment of the pixel areas in the image to a sensor field.
- the pixels of an area in the image are summed up during data acquisition, so that if the intermediate areas are well absorbed, the spectra for the sensor fields also become more meaningful.
- the further processing step (d) can comprise one of the following steps: (dl) elution of all bound viruses;
- step (d3) adding host cells to the entire surface; (d4) Adding host cells to selected surface fields In step (dl), the interacting viruses are removed from the
- step (d3) host cells are added to the entire surface and infected by the interacting viruses, followed by elution of the infected host cells from the surface.
- steps (d2) and (d4) only viruses are eluted that have interacted with the ligands immobilized on certain selected sensor fields.
- This is preferably achieved by the specifically designed volume element carrier 10, which is designed for this purpose as a body with recesses or bores as a grid mask, which is applied to the ligand field which contains the interacting ligand (s).
- the recesses of the grid mask are aligned in the same two-dimensional grid as the ligand fields on the carrier.
- the adjustment of both grids is achieved by the adjustment device (e.g. dowel pins) in the grid mask (volume carrier) and the carrier holder.
- step (d2) an eluence is given into those recesses of the grid mask which enclose ligand fields which contain interaction partners interacting with viruses on their sensor fields, followed by the elution of the interacting viruses from the surface.
- step (d4) host cells are placed in the recesses of the grid mask which contain sensor fields with which viruses have interacted, followed by the elution of the infected host cells from the surface.
- step (d2) or (d4) the interacting viruses or infected host cells of several recesses are propagated together.
- the method further comprises a multiplication step (e) which is carried out after step (d):
- the virus is propagated by diluting the infected cells in a pre-culture of the host strain and then growing the culture until lysis.
- Conditions for propagating the interacting viruses by infection of a host are well known to those skilled in the art, for example ® in T7Select System Manual, Fa. Novagen, Madison (USA) (TB178 06/00), page 18 et seq.
- the method further comprises a characterization step (f) which is carried out either after step (c) or after step (e):
- any type of assay which is suitable for characterizing a binding can be considered as an assay.
- Such an assay is preferably a solid phase assay.
- Methods known in the literature are, for example, ELISA (enzyme-linked immunosorbent assays), RIA (radioimmunoassay) and surface plasmon resonance (SPR) or vibration resonance methods (Butler, J.E., METHODS 22, 4-23 (2000).
- the binding is characterized in step (f) on the same or identical surface on which the virus population and the individual virus clones originating from this virus population have been identified and selected.
- a preferred embodiment of the method further comprises the isolation and sequencing step (g):
- Suitable methods are known to the person skilled in the art from the prior art which enable him to isolate and analyze the DNA sequences inserted into these, which code for the corresponding peptides or proteins, after the isolation of individual virus clones.
- the method further comprises the recombinant expression and isolation or the chemical synthesis of the peptide or protein identified / selected as interaction partner of the ligand.
- Expression systems and thus methods for the expression of isolated nucleic acid sequences and for the isolation of the encoded peptides and proteins are known. These expression systems include prokaryotic and eukaryotic systems. (See also Chapter 9.4 Expression Systems in: Mühlhardt, The Experimentator: Molecular Biology, Gustav Fischer Verlag 1999).
- the method further comprises characterizing the binding of the recombinantly expressed or chemically synthesized peptide or protein to individual ligands based on the selection of the ligands initially used in an assay.
- the same assays are advantageously used as are used for checking the virus clones. This is useful to get one from the virus demonstrate independent binding of the selected interaction partner.
- this characterization takes place on the same surface that was used for the identification / selection of the corresponding virus.
- the interaction partners presented by the viruses are encoded by DNA fragments inserted into the virus genome, which form a DNA library.
- the DNA library contains at least 10 2 , preferably 10 3 , even more preferably 10 4 , particularly preferably 10 5 , very particularly preferably 10 6 and most preferably 10 7 DNA fragments.
- the inserted DNA fragments are isolated from cDNA or genomic DNA (gDNA) or are synthetic oligo- or polynucleotides.
- the inserted cDNA or inserted gDNA preferably originates from a prokaryotic or eukaryotic organism.
- the eukaryotic organism is preferably a fungus, a plant or an animal organism, preferably a mammal.
- the mammal is preferably a mouse, a rat or a human.
- the cDNA is from a differentiated tissue or a differentiated one
- Cell population isolated Isolation of the cDNA from liver, brain, heart or breast tissue or cells is preferred.
- the tissues or cells preferably come from a healthy organism.
- the tissues or cells come from a diseased organism.
- Prefers is the disease or suffering of the organism selected from the group consisting of cancer, hypertrophy and inflammation.
- the viruses forming the virus system can include wild-type viruses and genetically modified viruses.
- the virus system comprises a virus which uses eukaryotes as the host.
- the virus system comprises a virus that uses prokaryotes as the host.
- the virus can have single-stranded DNA (ssDNA viruses), or can preferably be selected from the group of viruses with double-stranded DNA (dsDNA viruses).
- This dsDNA virus is more preferably selected from the group of bacteriophages.
- the bacteriophage is preferably selected from the group of the bacteriophages with tail, even more preferably selected from the group consisting of Myoviridae, Podoviridae or Siphoviridae.
- the bacteriophage is a bacteriophage specific for Escherichia coli.
- the bacteriophage can also be a filamentous bacteriophage and is preferably selected from M13, fl and fd phage.
- a virus system comprising a lytic phage is also preferred.
- This lytic phage preferably has a polyhedral, in particular an icosahedral, capsid.
- the lytic phage is a ⁇ phage, a T3 phage, a T4 phage or a T7 phage.
- the method can be used, for example, for epitope mapping or for peptide lead structure identification. Furthermore, the procedure is an ideal method to Identify ligands that make purification steps more efficient.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02787742A EP1451558A1 (de) | 2001-11-28 | 2002-11-20 | Spr-sensorflächenträger |
AU2002352069A AU2002352069A1 (en) | 2001-11-28 | 2002-11-20 | Surface plasmon resonance (spr) sensor surface support |
US10/855,261 US20040263853A1 (en) | 2001-11-28 | 2004-05-27 | SPR sensor surface support |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10158242 | 2001-11-28 | ||
DE10158242.0 | 2001-11-28 | ||
DE10220593A DE10220593A1 (de) | 2001-11-28 | 2002-05-08 | SPR-Sensorflächenträger |
DE10220593.0 | 2002-05-08 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/855,261 Continuation US20040263853A1 (en) | 2001-11-28 | 2004-05-27 | SPR sensor surface support |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003046526A1 true WO2003046526A1 (de) | 2003-06-05 |
Family
ID=26010669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/013008 WO2003046526A1 (de) | 2001-11-28 | 2002-11-20 | Spr-sensorflächenträger |
Country Status (4)
Country | Link |
---|---|
US (1) | US20040263853A1 (de) |
EP (1) | EP1451558A1 (de) |
AU (1) | AU2002352069A1 (de) |
WO (1) | WO2003046526A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2609023C (en) * | 2005-08-01 | 2012-11-27 | Canon Kabushiki Kaisha | Target substance detecting device, target substance detecting method using the same, and detecting apparatus and kit therefor |
KR101251538B1 (ko) | 2009-04-17 | 2013-04-08 | (주)아벨리노 | 아벨리노 각막이상증 진단용 프라이머 |
KR101041606B1 (ko) * | 2009-08-18 | 2011-06-15 | (주)아벨리노 | 다중 스팟 금속 증착형 나노구조배열 각막이상증 진단용 핵산칩 및 이의 제조방법 |
KR101125212B1 (ko) | 2010-10-01 | 2012-03-21 | (주)아벨리노 | 아벨리노 각막이상증 진단용 시스템 |
EP2711689B1 (de) * | 2011-05-19 | 2020-01-01 | Konica Minolta, Inc. | Oberflächenplasmonenfeldverstärkte fluoreszenzmessvorrichtung und fluoreszenznachweisverfahren damit |
JP2013181753A (ja) * | 2012-02-29 | 2013-09-12 | Nitto Denko Corp | Sprセンサセルおよびsprセンサ |
US10889850B2 (en) | 2013-03-15 | 2021-01-12 | Avellino Lab Usa, Inc. | Methods for improved isolation of genomic DNA templates for allele detection |
WO2014144874A1 (en) | 2013-03-15 | 2014-09-18 | Avellino Lab Usa, Inc. | Methods for improved isolation of genomic dna templates for allele detection |
AU2014348279B2 (en) | 2013-11-15 | 2021-02-18 | Avellino Lab Usa, Inc. | Methods for multiplex detection of alleles associated with ophthalmic conditions |
JP5983786B2 (ja) * | 2015-01-07 | 2016-09-06 | コニカミノルタ株式会社 | 表面プラズモン測定装置に用いられるセンサーチップおよびセンサーチップを用いた表面プラズモン測定装置 |
CN117295938A (zh) * | 2021-03-10 | 2023-12-26 | 尼科亚生命科学股份有限公司 | 表面等离子体共振信号放大 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0286195A2 (de) * | 1987-04-10 | 1988-10-12 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Verfahren und Anordnung zum Nachweis von schwachen Konzentrationen chemischer und biochemischer Komponenten in einem Untersuchungsmedium unter Verwendung der Oberflächenplasmon-Resonanz |
EP0341928A1 (de) * | 1988-05-10 | 1989-11-15 | AMERSHAM INTERNATIONAL plc | Oberflächen-Resonanzplasmawellen-Sensoren |
US5313264A (en) * | 1988-11-10 | 1994-05-17 | Pharmacia Biosensor Ab | Optical biosensor system |
WO1995022754A1 (en) * | 1994-02-16 | 1995-08-24 | Valtion Teknillinen Tutkimuskeskus | Device for carrying out an analysis |
EP0863395A2 (de) * | 1997-02-07 | 1998-09-09 | Fuji Photo Film Co., Ltd. | Oberflächen-Plasmonen-Sensor |
US5917607A (en) * | 1996-04-25 | 1999-06-29 | Fuji Photo Film Co., Ltd. | Surface plasmon sensor for multiple channel analysis |
WO2001013096A1 (de) * | 1999-08-13 | 2001-02-22 | Zeptosens Ag | Vorrichtung und verfahren zur multianalytbestimmung |
WO2001063256A1 (de) * | 2000-02-22 | 2001-08-30 | Graffinity Pharmaceutical Design Gmbh | Spr-sensorsystem |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4956303A (en) * | 1986-04-28 | 1990-09-11 | Antibody Technology Limited | Secondary antibodies against complexes of small molecules and binding partners therefor, their preparation, and their use in diagnostic methods |
US5468651A (en) * | 1987-11-28 | 1995-11-21 | Cambridge Patent Developments Limited | Method for determining haptens, use of method and components useful in method |
SE462454B (sv) * | 1988-11-10 | 1990-06-25 | Pharmacia Ab | Maetyta foer anvaendning i biosensorer |
US5242902A (en) * | 1989-09-06 | 1993-09-07 | The Regents Of The University Of California | Defensin peptide compositions and methods for their use |
US5616562A (en) * | 1990-04-27 | 1997-04-01 | Murphy; Christopher J. | Methods and compositions using substance P to promote wound healing |
ES2147178T3 (es) * | 1991-03-12 | 2000-09-01 | Biogen Inc | Dominio de union a cd2 del antigeno 3 asociado con la funcion linfocitica. |
MX9203138A (es) * | 1991-03-12 | 1992-09-01 | Biogen Inc | Dominio de enlace cd2-de antigeno 3 (lfa-3) asociado con funcion linfositos. |
GB9518429D0 (en) * | 1995-09-08 | 1995-11-08 | Pharmacia Biosensor | A rapid method for providing kinetic and structural data in molecular interaction analysis |
WO1997041255A1 (en) * | 1996-04-26 | 1997-11-06 | Massachusetts Institute Of Technology | Three-hybrid screening assay |
-
2002
- 2002-11-20 EP EP02787742A patent/EP1451558A1/de not_active Withdrawn
- 2002-11-20 WO PCT/EP2002/013008 patent/WO2003046526A1/de not_active Application Discontinuation
- 2002-11-20 AU AU2002352069A patent/AU2002352069A1/en not_active Abandoned
-
2004
- 2004-05-27 US US10/855,261 patent/US20040263853A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0286195A2 (de) * | 1987-04-10 | 1988-10-12 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Verfahren und Anordnung zum Nachweis von schwachen Konzentrationen chemischer und biochemischer Komponenten in einem Untersuchungsmedium unter Verwendung der Oberflächenplasmon-Resonanz |
EP0341928A1 (de) * | 1988-05-10 | 1989-11-15 | AMERSHAM INTERNATIONAL plc | Oberflächen-Resonanzplasmawellen-Sensoren |
US5313264A (en) * | 1988-11-10 | 1994-05-17 | Pharmacia Biosensor Ab | Optical biosensor system |
WO1995022754A1 (en) * | 1994-02-16 | 1995-08-24 | Valtion Teknillinen Tutkimuskeskus | Device for carrying out an analysis |
US5917607A (en) * | 1996-04-25 | 1999-06-29 | Fuji Photo Film Co., Ltd. | Surface plasmon sensor for multiple channel analysis |
EP0863395A2 (de) * | 1997-02-07 | 1998-09-09 | Fuji Photo Film Co., Ltd. | Oberflächen-Plasmonen-Sensor |
WO2001013096A1 (de) * | 1999-08-13 | 2001-02-22 | Zeptosens Ag | Vorrichtung und verfahren zur multianalytbestimmung |
WO2001063256A1 (de) * | 2000-02-22 | 2001-08-30 | Graffinity Pharmaceutical Design Gmbh | Spr-sensorsystem |
Also Published As
Publication number | Publication date |
---|---|
AU2002352069A1 (en) | 2003-06-10 |
EP1451558A1 (de) | 2004-09-01 |
US20040263853A1 (en) | 2004-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69836241T2 (de) | Verfahren zur Sichtung einer Bibliothek von chemischen Verbindungen | |
WO2006072306A1 (de) | Dreidimensionale nano- und mikrostrukturierte träger | |
EP1379545A2 (de) | Verfahren zur herstellung stabiler, regenerierbarer antikörper-arrays | |
EP1941276A1 (de) | Verfahren zur bestimmung eines oder mehrerer analyten in komplex zusammengesetzten proben biologischen ursprungs und dessen verwendung | |
EP0706646A1 (de) | Probenträger und seine verwendung | |
WO2005105308A1 (de) | Funktionalisierter poröser träger für mikroarrays | |
EP1277055B1 (de) | Biochip zur archivierung und labormedizinischen analyse von biologischem probenmaterial | |
EP1451558A1 (de) | Spr-sensorflächenträger | |
DE60225593T2 (de) | Immobilisierung von bindungsstoffen | |
EP1436609A2 (de) | Mikrofluidisches extraktionsverfahren | |
WO1998048275A1 (de) | Cluster verstärkter optischer sensor | |
WO2004023142A1 (de) | Analytische plattform und nachweisverfahren mit den in einer probe nachzuweisenden analyten als immobilisierten spezifischen bindungspartnern | |
WO2003056335A2 (de) | Mikrovertiefungsarray zur grössenabhängigen sortierung oder separation von in einer strömenden flüssigkeit suspendierten zellen und verfahren zur untersuchung der funktionellen aktivität von einzelzellen | |
WO2003046198A2 (de) | Verfahren zur selektion und identifikation von peptid- oder proteinmolekülen mittels phage display | |
EP1390139B1 (de) | Verfahren zur herstellung eines arrays zur detektion von komponenten aus einer biologischen probe | |
DE19925402C2 (de) | Screening von Target-Ligand-Wechselwirkungen | |
DE10220593A1 (de) | SPR-Sensorflächenträger | |
EP1745063B1 (de) | Verfahren zur herstellung von chemischen mikroarrays | |
EP1660568B1 (de) | Hydrophober gegenstand mit raster hydrophiler bereiche, dessen herstellung und verwendung | |
EP1360492B1 (de) | Probenträger für chemische und biologische proben | |
DE202006016699U1 (de) | Anordnung zum Erfassen von Substanzen, Herstellung der Anordnung und ihre Verwendung | |
EP1249499A1 (de) | Verfahren und Vorrichtung zur Bestimmung und Selektion von Molekül-Molekül-Wechselwirkungen | |
EP2217364A2 (de) | Flexibles extraktionsverfahren für die herstellung sequenzspezifischer molekülbibliotheken |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002787742 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10855261 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2002787742 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002787742 Country of ref document: EP |